In-Hospital and Long-Term Outcomes after Percutaneous Endoscopic Gastrostomy in Patients with Malignancy
Authors:
- Xiaoxia LiuXLXiaoxia Liu
- Afrin NuzhadANAfrin Nuzhad
- Guilherme RabinowitsGRGuilherme Rabinowits
- Vihas PatelVPVihas Patel
- 1 December 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (6) , 777-786
Abstract
Although percutaneous endoscopic gastrostomy (PEG) is widely performed for nutrition or palliation, PEG-associated outcomes in cancer patients remain poorly described. We examined the safety and benefits of PEG placement in this population at our institution. A 5-year retrospective review of patients with malignancy (excluding head/neck and thoracic malignancy) who underwent PEG at our institution was performed. One hundred and eighty-nine patients with malignancy underwent PEG; 33.9% had hematologic malignancy, 66.1% had nonhematologic malignancy, and 44.4% had metastatic disease. Indications for PEG were enteral access (73%) and gastric decompression/management of obstructive symptoms (27%). Few patients achieved independence from total parenteral nutrition (22%) or diet advancement (24.6%). Overall rates of major complications (eg, aspiration, tube dislodgement/leakage, bleeding, visceral injury, respiratory failure after procedure, and cardiac arrest) and minor complications (eg, superficial infection and ileus) were 10.2% and 11.3%, respectively. All-cause in-hospital mortality was high (19.6%) and was associated with ICU admission (p = 0.018), earlier bone marrow transplantation (p = 0.022), steroid treatment (p = 0.024), and lower preoperative albumin (p = 0.003). Code status was changed after PEG in 44 patients from full code to DNR/do no intubate or comfort measures only. Percutaneous endoscopic gastrostomy placement in this study population was associated with major procedure-related complications. The majority of patients failed to achieve total parenteral nutrition independence or advancement of diet. Nearly 25% of patients declined aggressive resuscitation strategies after undergoing surgery for PEG. This study cautions to carefully weigh the risks and benefits of PEG placement in this patient population. Prospective studies are needed to uncover factors affecting the decision process and patient selection.Keywords
This publication has 41 references indexed in Scilit:
- Risk of Bleeding After Percutaneous Endoscopic Gastrostomy (PEG)Digestive Diseases and Sciences, 2011
- Late accidental dislodgement of a percutaneous endoscopic gastrostomy tube: an underestimated burden on patients and the health care systemSurgical Endoscopy, 2011
- Prophylactic Percutaneous Endoscopic Gastrostomy Tube Placement in Treatment of Head and Neck CancerJournal of Parenteral and Enteral Nutrition, 2011
- Safety of pull-type and introducer percutaneous endoscopic gastrostomy tubes in oncology patients: a retrospective analysisBMC Gastroenterology, 2011
- Indications for percutaneous endoscopic gastrostomy and survival in old adultsFood & Nutrition Research, 2011
- Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort studyGastrointestinal Endoscopy, 2011
- Outpatient percutaneous endoscopic gastrostomy in selected head and neck cancer patientsSurgical Endoscopy, 2009
- Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary studyClinical Otolaryngology, 2007
- The Role of Endoscopically Placed Feeding or Decompression TubesGastroenterology Clinics of North America, 2006
- Ethics of palliative surgery in patients with cancerBritish Journal of Surgery, 2005